A Pilot Study Comparing a Low-dose Versus a High-dose Sublingual Buprenorphine Induction Dosing Scheme in Fentanyl Using Patients With Opioid Use Disorder (OUD)
Latest Information Update: 20 Mar 2025
At a glance
- Drugs Buprenorphine/naloxone (Primary)
- Indications Opioid-related disorders
- Focus Therapeutic Use
- 17 Mar 2025 Planned End Date changed from 31 Dec 2024 to 30 Oct 2025.
- 17 Mar 2025 Status changed from recruiting to active, no longer recruiting.
- 21 Feb 2024 Status changed from not yet recruiting to recruiting.